Ignite Creation Date:
2024-05-06 @ 7:34 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06063278
Status:
RECRUITING
Last Update Posted:
2023-10-02
First Post:
2022-04-28
Brief Title:
Step by Step Group Therapy for Bulimia Nervosa Effectiveness and Mechanisms of Change
Sponsor:
Fundació Institut de Recerca de lHospital de la Santa Creu i Sant Pau
Organization:
Fundació Institut de Recerca de lHospital de la Santa Creu i Sant Pau
Study Overview
Official Title:
Step by Step Group Therapy for Bulimia Nervosa Effectiveness and Mechanisms of Change
Status:
RECRUITING
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SBSBN
Brief Summary:
This a pseudo-randomized clinical trial that examines if a specific group therapy for BN is effective in improving its symptomatology and what variables mediate such improvements To do so a sample of 100 patients with BN will be pseudorandomized in a Group Therapy for BN or in a control waiting list group Patients will be assessed at baseline at the end of the group therapy and at 2 year follow up
Detailed Description:
This is a controlled non randomized study that will compare a group of patients with BN that participate in the SBS group therapy with a group of BN patients who will be in wait list as a control condition
Patients for this single center trial will be recruited from the outpatient facility of the Hospital de la Santa Creu I Sant Pau Barcelona Spain
After assessed for eligibility participants will be given a set of self -report questionnaires After the questionnaires are completed participants will be allocated to wait list condition or to the treatment arm Time between assessment and starting the SBS group will be a month or least Participants will be administered the same questionnaires the following month after finishing the treatment or after 3 to 4 months after the first assessment for the control condition
Patients for this single center trial will be recruited from the outpatient facility of the Hospital de la Santa Creu I Sant Pau Barcelona Spain
After assessed for eligibility participants will be given a set of self -report questionnaires After the questionnaires are completed participants will be allocated to wait list condition or to the treatment arm Time between assessment and starting the SBS group will be a month or least Participants will be administered the same questionnaires the following month after finishing the treatment or after 3 to 4 months after the first assessment for the control condition
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None